Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Next-generation sequencing of urologic cancers: next is now
Francisco X Real1, Paul C Boutros2, Núria Malats3
1Epithelial Carcinogenesis Group, CNIO-Spanish National Cancer Research Center, Madrid, Spain; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Abstract:
The exomes/genomes of a few hundred kidney, bladder, and prostate tumours have been sequenced. This sequencing has unveiled new genes that are altered and new opportunities for tumour subclassification, prediction of outcome, and therapy. These opportunities will soon become realities.
Insights
Sequencing kidney, bladder, and prostate tumors revealed new genes and improved methods for cancer subclassification, outcome prediction, and therapy. These advancements offer new hope for personalized cancer treatment strategies.
Area of Science:
- Oncology
- Genomics
- Cancer Research
Background:
- Genomic sequencing is crucial for understanding cancer development.
- Previous studies have laid the groundwork for large-scale tumor sequencing projects.
Purpose of the Study:
- To sequence the exomes/genomes of a significant number of kidney, bladder, and prostate tumors.
- To identify novel genetic alterations within these tumor types.
- To explore new avenues for cancer subclassification, prognosis prediction, and therapeutic targeting.
Main Methods:
- Whole exome sequencing
- Whole genome sequencing
- Bioinformatic analysis of tumor genomes
Main Results:
- Identification of previously unknown altered genes in kidney, bladder, and prostate cancers.
- Discovery of new molecular markers for tumor subclassification.
- Unveiling potential targets for improved outcome prediction and novel therapies.
Conclusions:
- Comprehensive genomic analysis of urological tumors provides a foundation for personalized medicine.
- The identified genetic alterations represent promising targets for future clinical applications.
- Advancements in sequencing technology are rapidly translating into tangible benefits for cancer patients.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Calculi VI: Surgical Management
Sanger Sequencing